
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials
Author(s) -
Eva Strijbis,
Pavle Repovic,
Jop Mostert,
James D. Bowen,
Bernard M. J. Uitdehaag,
Gary Cutter,
Marcus Koch
Publication year - 2022
Publication title -
multiple sclerosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.729
H-Index - 131
eISSN - 1477-0970
pISSN - 1352-4585
DOI - 10.1177/13524585221105465
Subject(s) - prom , medicine , expanded disability status scale , population , clinical trial , physical therapy , multiple sclerosis , physical medicine and rehabilitation , psychiatry , environmental health , obstetrics